59.20p+0.20 (+0.34%)17 Apr 2025, 16:56
Jump to:
Niox Group PLC Fundamentals
Company Name | Niox Group PLC | Last Updated | 2025-04-17 |
---|---|---|---|
Industry | Medical Devices | Sector | Healthcare |
Shares in Issue | 397.981 m | Market Cap | £235.60 m |
PE Ratio | 77.89 | Dividend per Share | £0.01 |
Dividend Yield | 1.69 | Dividend Cover | 0.76 |
EPS | £0.01 | EPS Growth (%) | -0.64 |
PEG | 0 | DPS Growth (%) | 0 |
Debt Ratio | 0.0219 | Debt Equity Ratio | 0.0134 |
Asset Equity Ratio | 1.1496 | Cash Equity Ratio | 0.1832 |
Quick Ratio | 2.1111 | Current Ratio | 2.60 |
Price To Book Value | 3.9604 | ROCE | 0 |
Niox Group PLC Dividends
Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
---|---|---|---|---|---|
Prelim | 2025-05-15 | 2025-06-16 | GBP | 0.0125 | |
Prelim | 2024-05-23 | 2024-06-24 | GBP | 0.0100 |
Niox Group PLC Company Financials
Assets | 2024 | 2023 | 2022 |
---|---|---|---|
Tangible Assets | £1.70 m | £1.40 m | £1.10 m |
Intangible Assets | £27.80 m | £32.80 m | £37.10 m |
Investments | 0 | 0 | 0 |
Total Fixed Assets | £47.30 m | £58.00 m | £67.10 m |
Stocks | £4.00 m | £4.80 m | £4.10 m |
Debtors | £6.20 m | £8.80 m | £7.90 m |
Cash & Equivalents | £10.90 m | £19.90 m | £19.40 m |
Other Assets | 0 | 0 | 0 |
Total Assets | £68.40 m | £91.50 m | £98.50 m |
Liabilities | 2024 | 2023 | 2022 |
---|---|---|---|
Creditors within 1 year | £8.10 m | £7.20 m | £9.20 m |
Creditors after 1 year | £800,000.00 | £500,000.00 | £7.40 m |
Other Liabilities | 0 | 0 | 0 |
Total Liabilities | £8.90 m | £7.70 m | £16.60 m |
Net assets | £59.50 m | £83.80 m | £81.90 m |
Equity | 2024 | 2023 | 2022 |
---|---|---|---|
Called up share capital | £300,000.00 | £300,000.00 | £300,000.00 |
Share Premium | £200,000.00 | £100,000.00 | £640.30 m |
Profit / Loss | £7.80 m | £4.10 m | £10.50 m |
Other Equity | £59.50 m | £83.80 m | £81.90 m |
Preference & Minorities | 0 | 0 | 0 |
Total Capital Employed | £59.50 m | £83.80 m | £81.90 m |
Ratios | 2024 | 2023 | 2022 |
---|---|---|---|
Debt Ratio | £0.01 | £0.01 | £0.00 |
Debt-to-Equity | £0.01 | £0.01 | £0.00 |
Assets / Equity | 1.1496 | 1.1496 | 1.1496 |
Cash / Equity | 0.1832 | 0.1832 | 0.1832 |
EPS | £0.01 | £0.02 | £0.03 |
Cash Flow | 2024 | 2023 | 2022 |
---|---|---|---|
Cash from operating activities | £17.20 m | £11.60 m | £6.70 m |
Cashflow before financing | -£7.90 m | £1.10 m | £6.20 m |
Increase in Cash | -£8.90 m | £800,000.00 | £6.10 m |
Income | 2024 | 2023 | 2022 |
---|---|---|---|
Turnover | £41.80 m | £36.80 m | £31.30 m |
Cost of sales | £11.60 m | £10.30 m | £9.10 m |
Gross Profit | £30.20 m | £26.50 m | £22.20 m |
Operating Profit | £7.70 m | £4.60 m | £1.80 m |
Pre-Tax profit | £7.80 m | £4.10 m | £10.50 m |
Niox Group PLC Company Background
Sector | Healthcare |
---|---|
Activities | NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the UnitedStates, the United Kingdom, and the Rest of the world. |
Latest Interim Date | 24 Sep 2024 |
Latest Fiscal Year End Date | 1 Apr 2025 |
Niox Group PLC Directors
Appointed | Name | Position |
---|---|---|
2025-04-01 | Mr. Michael Roy David Roller | Executive Director,Chief Financial Officer |
2025-04-01 | Mr. Garry Watts MBE | Non-Executive Director,Senior Independent Director |
2019-12-05 | Dr. Francesco Granata | Non-Executive Director,Chairman |
2025-04-01 | Mr. Ian Roy Johnson | Executive Director,Chairman |
2020-01-09 | Mr. Julien Fabrice Cotta | Executive Director,Chief Financial Officer and Company Secretary |
2019-12-26 | Mr. Steven Charles Andrew Harris | Executive Director,Chief Executive Officer |
2017-05-26 | Mr. Charles Stuart Webb Swingland | Non-Executive Director |
2016-12-16 | Ms. Cathrin Petty | Non-Executive Director |
2017-06-05 | Dr. Jean-Jacques Garaud | Non-Executive Director |
2017-05-26 | Dr. Timothy Henry Corn | Non-Executive Director |
2019-08-30 | Dr. Rod Hafner | Executive Director,Senior Vice President, RandD |
2025-04-01 | Mr. Jonathan Charles Emms | Executive Director,Chief Executive Officer |
2025-04-01 | Mr. Nicholas Harwood Bertram Mills | Non-Executive Director |
2025-04-11 | Mr. Robert Graham Naylor | Non-Executive Director |
Niox Group PLC Contact Details
Company Name | NIOX Group PLC |
---|---|
Address | Magdalen Centre, Robert Robinson Avenue, Northbrook House, Oxford Science Park, Oxford, OX4 4GA |
Telephone | +44 1865405560 |
Website | https://www.niox.com |
Niox Group PLC Advisors
Stockbroker | Numis Securities Limited |
---|---|
Phone | +44 2072601000 |
Fax | +44 2072601001 |
Bank | HSBC Bank PLC |
---|
Remuneration Consultant | New Bridge Street |
---|---|
Phone | +44 2070868000 |
Fax | +44 2076211511 |
Stockbroker | J.P. Morgan Cazenove Ltd |
---|---|
Phone | +44 2077424000 |
Financial PR Adviser | FTI Consulting Inc |
---|---|
Phone | +44 2037271000 |
Fax | +44 2037271007 |
Solicitor | Allen & Overy LLP |
---|---|
Phone | +44 2030880000 |
Fax | +44 207339999 |
Auditor | PricewaterhouseCoopers LLP |
---|---|
Phone | +44 2075835000 |
Fax | +44 2078224652 |
Registrar | Equiniti Limited |
---|
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine

Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
Company | Price | % Chg |
---|---|---|
Dunelm Group PLC | 1,074.00 | 13.29 |
Asos PLC | 313.50 | 6.63 |
Rentokil Initial PLC | 350.00 | 5.01 |
Sainsbury (J) PLC | 256.80 | 3.55 |
Dr. Martens PLC | 52.80 | 3.53 |
Pershing Square Holdings LTD | 3,414.00 | 3.45 |
Fallers
Company | Price | % Chg |
---|---|---|
Dowlais Group PLC | 51.40 | -6.03 |
Fresnillo PLC | 1,021.00 | -5.55 |
Jupiter Fund Management PLC | 69.30 | -5.07 |
Goodwin PLC | 6,780.00 | -4.51 |
Spectris PLC | 1,987.00 | -4.38 |
Twentyfour Income Fund Limited | 108.60 | -3.89 |
Risers/fallers data from previous trading day. Today's data available from 8:15am.